Issued Patents All Time
Showing 1–18 of 18 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11826421 | Bacteriophage-based vaccines and engineered bacteriophage | Michael Lebowitz | 2023-11-28 |
| 11369717 | Fibrous nerve conduit for promoting nerve regeneration | Niloofar Nazeri | 2022-06-28 |
| 10702591 | Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase | Biswajit Biswas, Carl R. Merril | 2020-07-07 |
| 10576069 | Treatment for chemotherapy-induced cognitive impairment | Zhi-Gang Jiang | 2020-03-03 |
| 10525044 | Treatment for chemotherapy-induced peripheral neuropathy | Zhi-Gang Jiang | 2020-01-07 |
| 10166303 | Radio-imaging and radio-therapy of cancer using antibodies to HAAH | Steven A. Fuller | 2019-01-01 |
| 9744223 | Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylase) | Biswajit Biswas, Carl R. Merril | 2017-08-29 |
| 7521479 | Methods of treating prion disease in mammals | Carl R. Merril | 2009-04-21 |
| 7456179 | Methods of treating ischemic related conditions | Bijan Almassian, Michael Lebowitz, Weiying Pan, Zhi-Gang Jiang | 2008-11-25 |
| 6942858 | Compositions containing bacteriophages and methods of using bacteriophages to treat infections | Paul Averback | 2005-09-13 |
| 6835370 | Diagnosis and treatment of malignant neoplasms | Jack R. Wands, Suzanne de la Monte, Alan H. Deutch | 2004-12-28 |
| 6518314 | Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions | Paul Averback, Iraj Beheshti, David L. Morse | 2003-02-11 |
| 6130221 | Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions | Paul Averback, Iraj Beheshti, David L. Morse | 2000-10-10 |
| 6121036 | Compositions containing bacteriophages and methods of using bacteriophages to treat infections | Paul Averback | 2000-09-19 |
| 5811310 | The Alz-50 monoclonal antibody and diagnostic assay for alzheimer's disease | Peter Davies, Benjamin Wolozin | 1998-09-22 |
| 5429947 | Diagnosing Alzheimer's disease and schizophrenia | Carl R. Merril, Ginger Johnson | 1995-07-04 |
| 5105007 | Phenylacetylglutamine (PAG) analytical test | Maciej Adamczyk, Donald Johnson | 1992-04-14 |
| 5100807 | Phenylacetylglutamine (PAG) analytical test | Maciej Adamczyk, Donald Johnson | 1992-03-31 |